Newsroom

MENTOR, Ohio--(BUSINESS WIRE)--Avery Dennison Announces Final Results and Upsize of Cash Tender Offers for Its Senior Notes...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--All amounts are in U.S. Dollars unless otherwise indicated: THIRD QUARTER 2026 HIGHLIGHTS Revenue, net of royalties was $18.3 million in the third quarter of 2026 compared to $15.0 million for the third quarter of 2025, which was an increase of 22% due to a 34% increase in average prices partially offset by a decrease in production of 9% Net income in the third quarter of 2026 was $3.6 million and Basic EPS was $0.10/share, which was the same as in the th...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100® Moderate Buffer UCITS ETF - March 12.11.2026 QMAR.LN IE0006S0EBF2   50,002.00 USD   1,265,987.32   25.319  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx NextG UCITS ETF 12.11.2026 NXTG.LN IE00BWTNM743  170,002.00 USD   9,012,563.37   53.014  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 12.11.2026 UINC IE00BZBW4Z27 11,030,415.00 USD 467,488,702.81   42.382  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 12.11.2026 QDEC.LN IE000GAKWFA7  250,002.00 USD   6,202,121.67   24.808  ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the approval of an expanded indication for ENFLONSIA® (clesrovimab) to include prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in children up to 24 months of age at increased risk for severe RSV dis...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 12.11.2026 FTAI IE000YIQZ0H6  225,002.00 USD   6,596,686.24   29.318  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 12.11.2026 MJUN LN IE000CO3P697  250,002.00 USD   6,417,520.75   25.670  ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of WELIREG® (belzutifan), Merck’s first-in-class oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, plus lenvatinib, the orally available multiple receptor tyrosine kinase inhibitor (TKI) discovered by Eisai, for the treatment of adult p...